journal article·2024-09-04

Size-Controllable and Monodispersed Lipid Nanoparticle Production with High mRNA Delivery Efficiency Using 3D-Printed Ring Micromixers

Jiwoo Hong, Sanghun Lee, Hyochan Park, Daehyeon Ahn, Jung Min Lee, Hyeongju Choe, Donghoon Kim, Ju Hee Kim, Chan Hee Chon

ACS Applied Materials & Interfaces· Volume 16· Issue 35
Publisher page

Abstract

Lipid nanoparticles (LNPs) are gaining recognition as potentially effective carriers for delivery of therapeutic agents, including nucleic acids (DNA and RNA), for the prevention and treatment of various diseases. Much effort has been devoted to the implementation of microfluidic techniques for the production of monodisperse and stable LNPs and the improvement of encapsulation efficiency. Here, we developed three-dimensional (3D)-printed ring micromixers for the production of size-controllable and monodispersed LNPs with a high mRNA delivery efficiency. The effects of flow rate and ring shape asymmetry on the mixing performance were initially examined. Furthermore, the physicochemical properties (such as hydrodynamic diameter, polydispersity, and encapsulation efficiency) of the generated LNPs were quantified as a function of these physical parameters via biochemical analysis and cryo-electron microscopy imaging. With a high production rate of 68 mL/min, our 3D-printed ring micromixers can be used to manufacture LNPs with diameters less than 90 nm, low polydispersity (<0.2), and high mRNA encapsulation efficiency (>91%). Despite the simplicity of the ring-shaped mixer structure, we can produce mRNA-loaded LNPs with exceptional quality and high throughput, outperforming costly commercial micromixers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Microfluidic and Bio-sensing Technologies · Nanopore and Nanochannel Transport Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Mechanical Engineering, Soongsil University, 369 Sangdo-Ro, Dongjak-Gu, Seoul 06978, Republic of Korea

Inventage Lab, 9F Uspce2 B, 670, Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13494, Republic of Korea

Funding

Korea National Institute of Health

References (35)

Show source-provided references
1. 10.1021/acsnano.1c0499610.1021/acsnano.1c04996 ↗
2. 10.1038/s41578-021-00400-110.1038/s41578-021-00400-1 ↗
3. 10.1021/acs.accounts.1c0054410.1021/acs.accounts.1c00544 ↗
4. 10.1002/anbr.20210010910.1002/anbr.202100109 ↗
5. 10.1016/j.addr.2022.11441610.1016/j.addr.2022.114416 ↗
6. 10.1021/acsmaterialsau.3c0003210.1021/acsmaterialsau.3c00032 ↗
7. 10.1021/acsnano.2c1258410.1021/acsnano.2c12584 ↗
8. 10.1021/acsomega.3c0832610.1021/acsomega.3c08326 ↗
9. 10.1517/17425247.2012.67327810.1517/17425247.2012.673278 ↗
10. 10.1016/j.jddst.2022.10352610.1016/j.jddst.2022.103526 ↗
11. 10.1016/j.addr.2022.11419710.1016/j.addr.2022.114197 ↗
12. 10.1021/acs.molpharmaceut.0c0091310.1021/acs.molpharmaceut.0c00913 ↗
13. 10.1016/j.jconrel.2022.02.01710.1016/j.jconrel.2022.02.017 ↗
14. 10.1016/j.addr.2018.03.00810.1016/j.addr.2018.03.008 ↗
15. 10.1016/j.biomaterials.2021.12082610.1016/j.biomaterials.2021.120826 ↗
16. 10.1039/D3LC00821E10.1039/D3LC00821E ↗
17. 10.1039/D3AN01739G10.1039/D3AN01739G ↗
18. 10.1016/j.ijpharm.2024.12414210.1016/j.ijpharm.2024.124142 ↗
19. 10.1039/D3LC00520H10.1039/D3LC00520H ↗
20. 10.1016/j.jddst.2024.10541110.1016/j.jddst.2024.105411 ↗
21. 10.1016/j.cej.2010.05.06810.1016/j.cej.2010.05.068 ↗
22. 10.1088/0960-1317/20/5/05500710.1088/0960-1317/20/5/055007 ↗
23. 10.1002/jctb.404410.1002/jctb.4044 ↗
24. 10.1016/j.bioactmat.2019.12.00310.1016/j.bioactmat.2019.12.003 ↗
25. 10.1007/s10404-015-1656-310.1007/s10404-015-1656-3 ↗
26. 10.1007/s00348-010-0954-510.1007/s00348-010-0954-5 ↗
27. 10.1016/j.measurement.2014.07.00410.1016/j.measurement.2014.07.004 ↗
28. 10.1038/s41598-022-13112-510.1038/s41598-022-13112-5 ↗
29. 10.1002/admi.20230108310.1002/admi.202301083 ↗
30. 10.1056/NEJMoa202790610.1056/NEJMoa2027906 ↗
31. 10.1038/s41586-021-03275-y10.1038/s41586-021-03275-y ↗
32. 10.1021/acsnano.2c1242010.1021/acsnano.2c12420 ↗
33. 10.1021/acs.molpharmaceut.3c0039010.1021/acs.molpharmaceut.3c00390 ↗
34. 10.1016/j.apmt.2023.10175410.1016/j.apmt.2023.101754 ↗
35. 10.1016/j.onano.2023.10016110.1016/j.onano.2023.100161 ↗